跳至主要内容
临床试验/CTIS2023-510299-29-00
CTIS2023-510299-29-00招募中1 期

TEM-GBM_001

Genenta Science S.p.A.0 个研究点目标入组 27 人开始时间: 2024年1月26日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

招募中
1 期
A study to see how well CVGBM vaccine works at different doses and how safe it is in patients who had surgery for glioblastoma or astrocytomaSurgically Resected Glioblastoma (GBM) or Astrocytoma with a Molecular Signature of Unmethylated GlioblastomaMedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10060971Term: Astrocytoma malignant Class: 100000004864
CTIS2022-501423-25-00Curevac AG54
招募中
1 期
A phase I of TG6050 in the treatment of patients with metastatic lung canceron-small cell lung cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code: 10059515Term: Non-small cell lung cancer metastatic Class: 100000004864
CTIS2024-513093-22-00Transgene36
进行中(未招募)
1 期
Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgerySubjects with newly diagnosed WHO Grade IV glioblastoma (ndGBM) who have undergone complete or partial tumor resectionMedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864
CTIS2024-511171-15-00Celgene Corp.216
进行中(未招募)
1 期
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of GTX-11 in Healthy SubjectsMedDRA version: 21.1Level: PTClassification code: 10021240Term: Idiopathic pulmonary fibrosis Class: 100000004855MedDRA version: 21.0Level: PTClassification code: 10037383Term: Pulmonary fibrosis Class: 100000004855MedDRA version: 21.1Level: LLTClassification code: 10022619Term: Interstitial pulmonary fibrosis Class: 10038738MedDRA version: 20.0Level: LLTClassification code: 10016660Term: Fibrosis pulmonary Class: 10038738Pulmonary fibrosis
CTIS2023-504426-19-00Gat Therapeutics S.L.60
招募中
1 期
A Study of NB003 in Patients With Advanced Malignancies
CTIS2022-502401-15-00ingbo Newbay Technology Development Co. Ltd.290